tert-Butyl 6-oxo-2,7-diazaspiro[4.5]decane-2-carboxylate
95%
- Product Code: 152165
CAS:
1228631-64-8
Molecular Weight: | 254.33 g./mol | Molecular Formula: | C₁₃H₂₂N₂O₃ |
---|---|---|---|
EC Number: | MDL Number: | MFCD16618554 | |
Melting Point: | Boiling Point: | ||
Density: | Storage Condition: | Room temperature, dry |
Product Description:
Used as an intermediate in pharmaceutical synthesis, particularly in the development of bioactive molecules and drug candidates. Its spirocyclic structure and functional groups make it valuable for constructing complex heterocyclic compounds. Commonly employed in medicinal chemistry for designing protease inhibitors and kinase inhibitors due to its ability to mimic peptide bonds and enhance metabolic stability. Also utilized in the preparation of novel compounds for neurological and oncological research.
Sizes / Availability / Pricing:
Size | Availability | Price | Quantity |
---|---|---|---|
0.100 | 10-20 days | $338.34 |
+
-
|
0.250 | 10-20 days | $574.96 |
+
-
|
1.000 | 10-20 days | $1,550.53 |
+
-
|
tert-Butyl 6-oxo-2,7-diazaspiro[4.5]decane-2-carboxylate
Used as an intermediate in pharmaceutical synthesis, particularly in the development of bioactive molecules and drug candidates. Its spirocyclic structure and functional groups make it valuable for constructing complex heterocyclic compounds. Commonly employed in medicinal chemistry for designing protease inhibitors and kinase inhibitors due to its ability to mimic peptide bonds and enhance metabolic stability. Also utilized in the preparation of novel compounds for neurological and oncological research.
Mechanism | - |
Appearance | - |
Longevity | - |
Strength | - |
Storage | - |
Shelf Life | - |
Allergen(s) | - |
Dosage (Range) | - |
Recommended Dosage | - |
Dosage (Per Day) | - |
Recommended Dosage (Per Day) | - |
Mix Method | - |
Heat Resistance | - |
Stable in pH range | - |
Solubility | - |
Product Types | - |
INCI | - |
Purchase History for
Loading purchase history...
Cart
No products
Subtotal:
$0.00
$0.00
Total :